For instance, in Amyotrophic Lateral Sclerosis (ALS), the effectiveness of ubiquitin–proteasome system (UPS)-mediated degradation of mutant superoxide dismutase 1 (SOD1) is a subject of ongoing debate. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.